Pharmaceutical assessment of polyvinylpyrrolidone (PVP): As excipient from conventional to controlled delivery systems with a spotlight on COVID-19 inhibition
書誌事項
- 公開日
- 2020-12
- 権利情報
-
- https://www.elsevier.com/tdm/userlicense/1.0/
- https://www.elsevier.com/legal/tdmrep-license
- https://doi.org/10.15223/policy-017
- https://doi.org/10.15223/policy-037
- https://doi.org/10.15223/policy-012
- https://doi.org/10.15223/policy-029
- https://doi.org/10.15223/policy-004
- DOI
-
- 10.1016/j.jddst.2020.102046
- 公開者
- Elsevier BV
この論文をさがす
収録刊行物
-
- Journal of Drug Delivery Science and Technology
-
Journal of Drug Delivery Science and Technology 60 102046-, 2020-12
Elsevier BV
